Navigation Links
NYU study points to lasting impact of mild hearing loss on neurological processes
Date:8/30/2007

Mild to moderate forms of hearing loss can have a lasting impact on the auditory cortex, according to findings by researchers at New York Universitys Center for Neural Science. The study, which is the first to show central effects of mild hearing loss, appears in the latest issue of the Journal of Neuroscience.

The study was authored by NYU scientists Han Xu, Vibhakar Kotak, and Dan Sanes, working in NYUs Center for Neural Science.

Previously, researchers had been unable to conclusively determine the neurological impact of mild forms of hearing loss, which occurs when the pathway by which sound reaches the cochlea is disruptedsuch as is experienced with middle ear infections during childhood. The NYU study sought to address this question in an animal model by measuring the impact of conductive hearing loss without injury to the cochlea.

The researchers induced hearing loss in the subjects during early development, then measured the functionality of neural connections within the subjects auditory cortex, which processes all acoustic cues.

The results showed that the projection to auditory cortex had changed following a brief period of hearing loss. Specifically, the researchers found that the synaptic response of the auditory neurons adapted more rapidly and to a greater extent. They also found that auditory cortex neurons became more sensitive to stimulation.

These findings indicate that auditory cortex function is susceptible to relatively modest loss of hearing loss during development and suggest that perceptual deficits may be linked to alterations in the central nervous system.


'/>"/>
Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
Source:Eurekalert

Page: 1

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: